Israel's Teva to pay $718 million in Israeli taxes


Save Story

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

JERUSALEM (AP) - Israel's Teva Pharmaceuticals Industries Ltd. says it has reached an agreement with the country's tax authority to pay roughly $718 million to settle a series of claims against the drug maker.

The money will settle tax assessments on "trapped profits," earnings that result from special corporate tax breaks, and pay separate back taxes.

Teva, the world's largest generic drug maker, has long been a source of pride in Israel. But the company's image has been tarnished by plans for mass layoffs, including hundreds of jobs in Israel.

The layoff plans caused uproar in Israel, where the company has enjoyed years of tax breaks and other incentives, and forced Teva's chief executive to step down last month.

Acting CEO Eyal Desheh said Monday's agreement was "beneficial" for both Teva and Israel.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Most recent World stories

Related topics

KSL.com Beyond Series
KSL.com Beyond Business

KSL Weather Forecast

KSL Weather Forecast
Play button